IL-17A increases doxorubicin efficacy in triple negative breast cancer. IL-17A increases doxorubicin efficacy in triple negative breast cancer

Name: IL-17A increases doxorubicin efficacy in triple negative breast cancer. IL-17A increases doxorubicin efficacy in triple negative breast cancer
Published: 2022-06-06T00:00:00+08:00

NIAID Data Ecosystem2026-03-13 收录

三阴性乳腺癌

药物联合疗效机制

数据链接：

https://www.ncbi.nlm.nih.gov/bioproject/PRJNA846314 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series

创建时间：

2022-06-06

IL-17A increases doxorubicin efficacy in triple negative breast cancer. IL-17A increases doxorubicin efficacy in triple negative breast cancer

资源简介：

相关数据集